Antibody

AntibodystaleUniversity of ChicagoPhase 2

for example: pembrolizumab, cemiplimab, durvalumab, ipilimumab plus nivolumab (Investigator Choice Immunotherapy, Investigator Choice Immunotherapy (for example: pembrolizumab, cemiplimab, durvalumab, ipilimumab plus nivolumab))

Non-Small Cell Lung Cancer; Metastatic Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase2#항체#면역항체+3

AntibodystaleSir Run Run Shaw HospitalPhase 2

Ipalolimab and Tovorilimab (Ipalolimab and Tovorilimab)

dMMR/MSI-H-type Rectal Adenocarcinoma · dMMR/MSI-H-type Rectal Adenocarcinoma

#dMMRMSI-H-typeRectalAdenocarcino#Antibody#Phase2#항체#면역항체+4

AntibodystaleFudan UniversityPhase 2

Iparomlimab and Tuvoraleimab injection+Bevacizumab+Pemetrexed+Cisplatin (Iparomlimab and Tuvoraleimab injection+Bevacizumab+Pemetrexed+Cisplatin)

Mesothelioma · Mesothelioma

#Mesothelioma#Antibody#Phase2#항체#면역항체+2

AntibodystaleTianjin Medical University Canc…Phase 2

Iparomlimab and tuvonralimab (Iparomlimab and tuvonralimab)

HCC - Hepatocellular Carcinoma; Iparomlimab and Tuvonralimab Injection · mCRC

#mCRC#Antibody#Phase2#항체#면역항체+4

#StageIIIIVMelanoma#Antibody#Phase2#항체#면역항체+4

Ipilimumab IT (Ipilimumab IT)

Stage III/IV Melanoma · Stage III/IV Melanoma

효능 ORR 21.4%임상시험 1상태 ACTIVE

#MalignantMelanoma#Antibody#Phase2#항체#면역항체+2

Ipilimumab Injection [Yervoy] (Ipilimumab Injection [Yervoy])

Malignant Melanoma · Malignant Melanoma

#MetastaticMalignantMelanoma#Antibody#Phase2#항체#면역항체+2

Ipilimumab and Fotemustine (Ipilimumab and Fotemustine)

Metastatic Malignant Melanoma · Metastatic Malignant Melanoma

#Melanoma#Antibody#Phase2#항체#면역항체+3

nivolumab (Opdivo, Ipilimumab plus nivolumab plus guadecitabine)

Melanoma; Non Small Cell Lung Cancer · Melanoma

#MetastaticCancer#Antibody#Phase2#항체#면역항체+3

pembrolizumab (Keytruda, Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab)

Metastatic Cancer; Melanoma Cancer · Metastatic Cancer

AntibodystaleBristol Myers SquibbPreclinical

pembrolizumab (Keytruda, Ipilimumab, nivolumab or pembrolizumab)

Brain Metastases · Brain Metastases

#BrainMetastases#Antibody#Preclinical#항체#면역항체+2

#MetastaticMelanoma#Antibody#Phase2#항체#면역항체+2

Ocular (Ipilimumab: Cohort 2, Ipilimumab: Cohort 2 (Ocular))

Metastatic Melanoma · Metastatic Melanoma

효능 ORR 1%임상시험 1상태 ACTIVE

AntibodystaleBrown UniversityPhase 2

Ipilumumab (Ipilumumab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase2#항체#면역항체+2

AntibodystaleInSightecPhase 3

Iptilimumab (Iptilimumab)

Brain Tumor; Non Small Cell Lung Cancer · Brain Tumor

#BrainTumor#Antibody#Phase3#항체#면역항체+3

AntibodystaleAstraZenecaPhase 1

administered with & without Cetuximab (Irinotecan, Irinotecan (administered with & without Cetuximab))

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#항체#면역항체+2

AntibodystaleEli LillyPhase 2

Irinotecan Liposomes (II, Irinotecan Liposomes, Irinotecan Liposomes (II)+Cetuximab+Bevacizumabl)

Colorectal Cancer Metastatic · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase2#항체#면역항체+2

AntibodystaleThe Fourth Affiliated Hospital …Phase 2

Irinotecan liposome combined with capecitabine, bevacizumab and camrelizumab (Irinotecan liposome combined with capecitabine, bevacizumab and camrelizumab)

Metastatic Colorectal Cancer (CRC) · Metastatic Colorectal Cancer (CRC)

#MetastaticColorectalCancerCRC#Antibody#Phase2#항체#면역항체+2

AntibodystaleGruppo Italiano per lo studio d…Phase 3

Irinotecan/Cetuximab (Irinotecan/Cetuximab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2

AntibodystaleSanofiPhase 2

Isatuximab SC-OBDS (Isatuximab SC-OBDS)

Plasma Cell Myeloma Refractory · FRα

#FR#Antibody#Phase2#항체#면역항체+3

AntibodystaleSun Yat-sen UniversityPhase 2

Ivonescimab Combined With Chemotherapy (Ivonescimab Combined With Chemotherapy)

Relapsed or Metastatic Thymic Cancer; First-line Treatment · Relapsed or Metastatic Thymic Cancer

#RelapsedorMetastaticThymicCancer#Antibody#Phase2#항체#면역항체+3